Endpoints News
Endpoints News delivers timely and in-depth coverage of the biotechnology and pharmaceutical industries, focusing on drug development, regulatory affairs, and market trends.
Latest News
- Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report
- AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGen
- Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratory
- FDA again rejects Atara, Pierre Fabre's cell therapy for Epstein-Barr virus
- Arkin Capital raises $100M to back a dozen early-stage biotechs
- #JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
- #JPM26: Day 1 at the JP Morgan Healthcare Conference